US 11236080
Protein kinase inhibitors
granted A61KA61K31/506A61K45/06
Quick answer
US patent 11236080 (Protein kinase inhibitors) held by Princeton Drug Discovery, Inc expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Princeton Drug Discovery, Inc
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/506, A61K45/06, A61P, A61P25/28